Table 3. Association of eGFR Calculation Method With Time to Achievement of an eGFR Less Than 20 mL/min/1.73 m2.
Overall | Baseline eGFR (CKD-EPIRC), mL/min/1.73 m2 | ||||
---|---|---|---|---|---|
<30 | 30 to <45 | 45 to <60 | ≥60 | ||
CKD-EPIRC | |||||
No. at riska | 1616 | 278 | 605 | 498 | 235 |
No. of events | 462 | 158 | 197 | 87 | 20 |
Incidence rate, per 100 person-years (95% CI) | 4.8 (4.4 to 5.3) | 22.2 (18.6 to 25.8) | 6.2 (5.4 to 7.1) | 2.4 (1.9 to 2.8) | 1.0 (0.6 to 1.4) |
CKD-EPIWRC | |||||
No. at riska | 1616 | 278 | 605 | 498 | 235 |
No. events | 589 | 199 | 253 | 112 | 25 |
Incidence rate, per 100 person-years (95% CI) | 6.5 (6 to 7.1) | 41.2 (33.1 to 49.2) | 8.6 (7.5 to 9.6) | 3.1 (2.6 to 3.7) | 1.3 (0.8 to 1.8) |
CKD-EPICYS | |||||
No. at riska | 1616 | 278 | 605 | 498 | 235 |
No. of events | 448 | 155 | 189 | 87 | 17 |
Incidence rate, per 100 person-years (95% CI) | 4.9 (4.4 to 5.3) | 22.9 (18.5 to 27.2) | 6.2 (5.3 to 7.0) | 2.4 (2.0 to 2.9) | 0.9 (0.5 to 1.3) |
Difference in incidence rate, per 100 person-years (95% CI)b | |||||
CKD-EPIWRC – CKD-EPIRC | 1.7 (1.4 to 2.0) | 19.0 (13.3 to 24.7) | 2.3 (1.8 to 2.9) | 0.8 (0.5 to 1.0) | 0.3 (0.0 to 0.5) |
CKD-EPICYS – CKD-EPIRC | 0.0 (−0.3 to 0.4) | 0.7 (−2.6 to 3.9) | −0.1 (−0.7 to 0.6) | 0.1 (−0.3 to 0.5) | −0.1 (−0.6 to 0.3) |
Hazard ratioc | |||||
CKD-EPIWRC vs CKD-EPIRC | 1.35 (1.29 to 1.41)d | 1.81 (1.61 to 2.03) | 1.38 (1.28 to 1.48) | 1.32 (1.19 to 1.46) | 1.26 (1.03 to 1.53) |
CKD-EPICYS vs CKD-EPIRC | 1.01 (0.94 to 1.08)e | 1.02 (0.89 to 1.18) | 1.00 (0.9 to 1.11) | 1.05 (0.89 to 1.25) | 0.89 (0.56 to 1.42) |
Abbreviations: CKD, chronic kidney disease; CKD-EPICYS, cystatin C–based CKD-EPI eGFR; CKD-EPIRC, creatinine-based CKD-EPI eGFR calculated with the race coefficient; CKD-EPIWRC, creatinine-based CKD-EPI eGFR calculated without the race coefficient; eGFR, estimated glomerular filtration rate.
Includes all participants with an eGFR (CKD-EPIRC) of at least 20 mL/min/1.73 m2 at study entry.
Difference in incidence rates per 100 person-years without minus with the race coefficient.
Instantaneous risk of an eGFR less than 20 mL/min/1.73 m2 associated with use of the race coefficient.
P < .001.
P = .85.